Insights into antibiotic resistance promoted by quinolone exposure
Antimicrobial Agents and Chemotherapy · 31.01.2025 · 69 (1)
DOI: 10.1128/aac.00997-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 31.01.2025. Verfasst von Natassja G Bush und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Chemistry, John Innes Centre, Norwich Research Park, Norwich, United Kingdom. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Escherichia coli, Quinolones, Drug Resistance, Bacterial. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, UKRI | Biotechnology and Biological Sciences Research Council (BBSRC).
Abstract (Originalsprache)
Quinolone-induced antibiotic resistance (QIAR) refers to the phenomenon by which bacteria exposed to sublethal levels of quinolones acquire resistance to non-quinolone antibiotics. We have explored this in Escherichia coli MG1655 using a variety of compounds and bacteria carrying a quinolone-resistance mutation in gyrase, mutations affecting the SOS response, and mutations in error-prone polymerases. The nature of the antibiotic-resistance mutations was determined by whole-genome sequencing. Exposure to low levels of most quinolones tested led to mutations conferring resistance to chloramphenicol, ampicillin, kanamycin, and tetracycline. The mutations included point mutations and deletions and could mostly be correlated with the resistance phenotype. QIAR depended upon DNA gyrase and involved the SOS response but was not dependent on error-prone polymerases. Only moxifloxacin, among the quinolones tested, did not display a significant QIAR effect. We speculate that the lack of QIAR with moxifloxacin may be attributable to it acting via a different mechanism. In addition to the concerns about antimicrobial resistance to quinolones and other compounds, QIAR presents an additional challenge in relation to the usage of quinolone antibacterials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Chemistry, John Innes Centre, Norwich Research Park, Norwich, United Kingdom.
- School of Biological Sciences, University of East Anglia School of Biological Sciences, Norwich, United Kingdom.
- Earlham Institute, Norwich Research Park, Norwich, United Kingdom.
- Department of Molecular Microbiology, John Innes Centre, Norwich Research Park, Norwich, United Kingdom.
ORCID-Profile: Natassja G Bush, Isabel Diez-Santos, Anthony Maxwell
Förderung
- Wellcome Trust
- UKRI | Biotechnology and Biological Sciences Research Council (BBSRC)
Zitieren
APA
Bush, N. G., Diez-Santos, I., Sankara Krishna, P., Clavijo, B., & Maxwell, A. (2025). Insights into antibiotic resistance promoted by quinolone exposure. Antimicrobial Agents and Chemotherapy, 69(1). https://doi.org/10.1128/aac.00997-24
Vancouver
Bush NG, Diez-Santos I, Sankara Krishna P, Clavijo B, Maxwell A. Insights into antibiotic resistance promoted by quinolone exposure. Antimicrobial Agents and Chemotherapy. 2025;69(1). doi:10.1128/aac.00997-24
BibTeX
@article{Bush2025,
author = {Bush, Natassja G and Diez-Santos, Isabel and Sankara Krishna, Pilla and Clavijo, Bernardo and Maxwell, Anthony},
title = {Insights into antibiotic resistance promoted by quinolone exposure},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
volume = {69},
number = {1},
doi = {10.1128/aac.00997-24}
}
EUVIMED